|
|
Volumn 458, Issue 7235, 2009, Pages 131-132
|
|
Personalized cancer therapy gets closer
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
APC PROTEIN;
BETA CATENIN;
DNA;
EPIDERMAL GROWTH FACTOR RECEPTOR;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
ERLOTINIB;
FLT3 LIGAND;
JANUS KINASE 2;
NOTCH RECEPTOR;
PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;
PROTEIN P53;
PROTEIN RET;
STEM CELL FACTOR;
SUNITINIB;
BRAIN CANCER;
BREAST CANCER;
CANCER GENETICS;
CANCER THERAPY;
COLORECTAL CANCER;
COST;
DIGESTIVE SYSTEM CANCER;
DNA SEQUENCE;
DRUG TARGETING;
GENE MUTATION;
GENETIC SCREENING;
HEAD AND NECK CANCER;
HEALTH ECONOMICS;
HUMAN;
HUMAN GENOME;
LUNG CANCER;
NOTE;
ONCOLOGY;
PRIORITY JOURNAL;
RECEPTOR GENE;
SKIN CANCER;
SOFT TISSUE CANCER;
THYROID CANCER;
TUMOR GENE;
TUMOR SUPPRESSOR GENE;
UROGENITAL TRACT CANCER;
ANTINEOPLASTIC AGENTS;
DRUG DELIVERY SYSTEMS;
GENETIC SCREENING;
HUMANS;
MEDICAL ONCOLOGY;
MUTATION;
NEOPLASMS;
|
|
EID: 62249112106
PISSN: 00280836
EISSN: 14764687
Source Type: Journal
DOI: 10.1038/458131a Document Type: Note |
|
Times cited : (46)
|
|
References (3)
|
